Advertisement
Screener

Dolby Laboratories, Inc. (DLB) Overview

Dolby Laboratories, Inc. (DLB) Overview

  • 28 Mar 2026: Period ending 26 Jun 2026; Estimate (m); Actual 0.30; Beat / miss (m).
  • 27 Dec 2025: Period ending 27 Mar 2026; Estimate (m); Actual 0.99; Beat / miss (m).
  • 27 Sept 2025: Period ending 26 Dec 2025; Estimate (m); Actual 0.55; Beat / miss (m).
  • 29 Mar 2025: Period ending 27 Jun 2025; Estimate (m); Actual 0.48; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$46.08$50.57$55.49$60.90$66.82$73.332025-11-062026-11-06$46.08$53.96$63.17$73.96$86.60$101.392021-11-082026-11-06$42.92$52.20$63.48$77.19$93.87$114.152016-11-072026-11-06$18.75$27.70$40.93$60.47$89.33$131.972006-11-062026-11-06$14.25$22.24$34.71$54.18$84.56$131.972005-02-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$64.83
Previous close
$57.93
Change
$6.90
Change (%)
11.90%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

DLB
-8.21%
S&P 500
(m)

1 year

DLB
-18.17%
S&P 500
(m)

3 years

DLB
-22.80%
S&P 500
(m)

5 years

DLB
-29.19%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

26 Jun 2026 ○ Estimate (m) ● Actual 0.30

0.220.460.690.931.1728 Mar 2025: estimate (m); actual 0.9428 Mar 2025(m)27 Jun 2025: estimate (m); actual 0.4827 Jun 2025(m)26 Dec 2025: estimate (m); actual 0.5526 Dec 2025(m)27 Mar 2026: estimate (m); actual 0.9927 Mar 2026(m)26 Jun 2026: estimate (m); actual 0.3026 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
28 Mar 202626 Jun 2026(m)0.30(m)(m)
27 Dec 202527 Mar 2026(m)0.99(m)(m)
27 Sept 202526 Dec 2025(m)0.55(m)(m)
29 Mar 202527 Jun 2025(m)0.48(m)(m)
28 Dec 202428 Mar 2025(m)0.94(m)(m)

26 Sept 2025 ○ Estimate (m) ● Actual 2.62

1.732.082.442.803.1524 Sept 2021: estimate (m); actual 2.9724 Sept 2021(m)30 Sept 2022: estimate (m); actual 1.8130 Sept 2022(m)29 Sept 2023: estimate (m); actual 2.0529 Sept 2023(m)27 Sept 2024: estimate (m); actual 2.6927 Sept 2024(m)26 Sept 2025: estimate (m); actual 2.6226 Sept 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
28 Sept 202426 Sept 2025(m)2.62(m)(m)
30 Sept 202327 Sept 2024(m)2.69(m)(m)
1 Oct 202229 Sept 2023(m)2.05(m)(m)
25 Sept 202130 Sept 2022(m)1.81(m)(m)
26 Sept 202024 Sept 2021(m)2.97(m)(m)

Revenue vs. Earnings

USD

26 Jun 2026 ■ Revenue 305.00M ■ Earnings 28.60M — Profit margin 9.38%

-47.48M8.4%116.05M13.9%279.58M19.5%443.11M25.0%27 Jun 2025: revenue 315.55M; earnings 46.07M; profit margin 14.60%27 Jun 202526 Dec 2025: revenue 346.71M; earnings 53.33M; profit margin 15.38%26 Dec 202527 Mar 2026: revenue 395.63M; earnings 94.92M; profit margin 23.99%27 Mar 202626 Jun 2026: revenue 305.00M; earnings 28.60M; profit margin 9.38%26 Jun 2026

26 Sept 2025 ■ Revenue 1.35B ■ Earnings 0.26B — Profit margin 18.90%

-0.16B13.7%0.40B16.3%0.95B18.9%1.51B21.6%30 Sept 2022: revenue 1.25B; earnings 0.18B; profit margin 14.68%30 Sept 202229 Sept 2023: revenue 1.30B; earnings 0.20B; profit margin 15.44%29 Sept 202327 Sept 2024: revenue 1.27B; earnings 0.26B; profit margin 20.56%27 Sept 202426 Sept 2025: revenue 1.35B; earnings 0.26B; profit margin 18.90%26 Sept 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$64.83(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$64.83High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning DLB

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 26 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$226.18M
Profit margin
16.70%
Return on assets · 12 month
7.12%
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
987.24K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-0.79%*
Total return · month
-5.83%*
Total return · quarter
11.79%*
Total return · half year
1.03%*
Total return · year to date
-8.21%*
Total return · 1 year
-18.17%*
Total return · 3 years
-22.80%*
Total return · 5 years
-29.19%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$1.35B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Dolby Laboratories, Inc. Overview

View more →

(m)

(m)

SEC CIK
1308547
Industry (SIC)
6794 Patent Owners & Lessors
Country of operation
United States
Business address
1275 MARKET STREET, SAN FRANCISCO, California, 94103, United States
Fiscal year end
0927
Phone
415 558 0200